ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,744Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 663

$715K Total Retail Price of All Prescriptions

Rank: 25 out of 663

409 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,994 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 421 351 1 3
FUROSEMIDE 366 281 2 7
LISINOPRIL 352 272 3 2
SIMVASTATIN 281 247 4 1
HYDROCODONE-ACETAMINOPHEN 254 165 S3 5 6
WARFARIN SODIUM 233 157 6 8
AMLODIPINE BESYLATE 206 183 7 5
METOPROLOL TARTRATE 192 134 8 11
OXYCODONE HCL 185 38 S2 9 41
GABAPENTIN 178 98 10 20
LANTUS 174 144 11 48
OMEPRAZOLE 167 134 12 4
CARVEDILOL 154 136 13 47
POTASSIUM CHLORIDE 135 102 14 23
OXYCODONE-ACETAMINOPHEN 133 43 S2 15 26
METFORMIN HCL 125 88 16 9
CYMBALTA 123 65 17 54
CITALOPRAM HBR 120 104 18 18
NAMENDA 116 116 19 57
QUETIAPINE FUMARATE 115 94 20 69
ZOLPIDEM TARTRATE 107 81 21 16
TRAMADOL HCL 107 90 21 17
DONEPEZIL HCL 102 102 23 40
LOVASTATIN 95 65 24 30
ALLOPURINOL 93 92 25 28
RANITIDINE HCL 92 60 26 31
PRAVASTATIN SODIUM 88 82 27 21
PREDNISONE 82 73 28 39
ALENDRONATE SODIUM 80 69 29 15
LIDODERM 77 51 30 67
GLIPIZIDE 75 57 31 29
RISPERIDONE 75 54 31 87
CIPROFLOXACIN HCL 70 54 33 74
DIOVAN 69 69 34 59
METOPROLOL SUCCINATE 69 65 34 25
NEXIUM 69 44 34 43
ATORVASTATIN CALCIUM 69 62 34 13
FENTANYL 68 21 S2 38 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 57 39 22
ROPINIROLE HCL 63 51 40 140
MIRTAZAPINE 63 63 40 52
PANTOPRAZOLE SODIUM 63 57 40 45
JANUVIA 61 46 43 78
BYSTOLIC 58 57 44 116
NOVOLIN R 57 45 45 106
METFORMIN HCL ER 56 43 46 90
FLUTICASONE PROPIONATE 56 40 46 27
OXYBUTYNIN CHLORIDE ER 55 34 48 121
METHADONE HCL 55 11 S2 48 126
MORPHINE SULFATE ER 53 0 S2 50 51
SERTRALINE HCL 51 27 51 35
GLIMEPIRIDE 50 50 52 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.